Automated Detection of Brain Metastases on MRI
- Sponsor
- Robovision BV
- Study ID
- NCT06727032
- Status
- Enrolling By Invitation
Conditions
- Brain Metastases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Brain Metastasis AI — DEVICEThere will be no intervention
Study Details
This reader study aims at assessing whether the radiologist aided with AI software has at least a non-inferior performance than without AI assistance in detecting brain metastases. 200 retrospective MRI images will be included in the study with 100 positive and 100 negative exams. Assessment will be completed by 12 readers with varying level of experience. This is a Retrospective Multiple-Reader Multiple-Case (MRMC) randomised study.
Key Dates
- First listed
- Dec 10, 2024
- Start date
- Jan 24, 2025
- Status verified
- Aug 2025
- Primary completion
- Sep 30, 2025
- Completion
- Oct 31, 2025
Study Design
- Enrollment
- 12 participants (estimated)
Primary Outcome Measure
Detection accuracy [ Time Frame: 3 months ]
Related Studies
- Stereotactic Radiosurgery Dose Escalation for Brain MetastasesPHASE1 · Recruiting · University of Utah · Salt Lake City, Utah
- Frameless Stereotactic Radiosurgery for Intact Brain MetastasesPHASE2 · Recruiting · University of Chicago · Chicago, Illinois
- Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsPHASE1/PHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain MetastasesPHASE3 · Recruiting · Canadian Cancer Trials Group · Tucson, Arizona